Gamma Knife System Market size is estimated to grow at a valuation of USD 812.5 Million by 2035; Rising Preference of Patients for Minimally Invasive Treatment Options is Stimulating the Market Augmentation

Download Sample

Published Date: September 2025

Gamma knife system, a radiosurgery device, uses gamma radiation to treat small brain and head tumors. The gamma knife system market growth is driven by the increasing prevalence of neurological disorders, preference for minimally invasive treatments, and the development of new systems with improved precision and flexibility. Advances in treatment planning software further drive market expansion.

Segmentation Analysis:

By Product Type	Head Gamma Knife System, and Body Gamma Knife System
By Disease Indication	Brain Metastasis, Cancer, Arteriovenous Malformation (AVM), Trigeminal Neuralgia, and Others
By End User	Hospitals, Specialty Clinics, Radiotherapy Centers, and Others

Report Highlights:

Gamma knife system market size is accounted at USD 505 Million in 2025.
Target market size is expected to develop at a rate of USD 812.5 Million by 2035 and at a CAGR of 5.4%.
Appertaining from product type, the head gamma knife system is the leading product type of the gamma knife system market share.
On the basis of disease indication, the brain metastasis segment is expected to rule over the gamma knife system market size.
By end user, hospitals have the most gamma knife system market share.
Geographically, Asia Pacific is the region which is attributed to dominate the gamma knife system market share.
North America is the region which has the gamma knife system market growing with the fastest growth rate, during the forecast period.

Market Dynamics:

Growing Factor	Challenge Factor	Market Trend
Rising Prevalence Of Neurological Disorders	Brain Swelling Caused Due To Gamma Knife System	Development Of New Gamma Knife System

Key Highlights:

In April 2024, the AdventHealth Neuroscience Institute became the first in Central Florida to treat brain patients with the Elekta Esprit Gamma Knife. This advanced stereotactic radiosurgery (SRS) system delivers ablative radiation with pinpoint precision to targets in the brain while sparing surrounding healthy brain tissue. The new Gamma Knife platform can treat a variety of malignant and benign conditions using a minimally invasive approach.

Report Analysis:

Daily Quality Assurance of Gamma Knife Systems:

Gamma Knife quality assurance testing is performed by an authorized medical physicist every morning. The purpose of Daily Quality Assurance is to assure proper system function in standard treatment conditions plus verify all safety and emergency functions. The medical physicist ensures that all system tests required by Nuclear Regulatory Commission (NRC) regulations are performed and functioning properly.

These tests include the permanently mounted radiation monitor inside the treatment room and it’s remote indicator, hand held radiation monitor, patient viewing and communication systems, door interlock, timer termination of exposure, treatment pause and emergency stops, test of all required beam status indicators and alarm indicators, availability of the release rods for the emergency removal of a patient and function of the helmet hoist used for collimator helmet exchange. A test run simulating the standard treatment procedure is performed and also includes check of automatic positioning system accuracy test.

Browse ∼70 market data tables and ∼65 figures through ∼190 slides and in-depth TOC on “Gamma Knife System Market, By Product Type (Head Gamma Knife System, and Body Gamma Knife System), Disease Indication (Brain Metastasis, Cancer, Arteriovenous Malformation (AVM), Trigeminal Neuralgia, and Others), End User (Hospitals, Specialty Clinics, Radiotherapy Centers, and Others), and By Region - Trends, Analysis, and Forecast till 2035”

Segmentation:

By Product Type:

Head Gamma Knife System
Body Gamma Knife System

By Disease Indication:

Brain Metastasis
Cancer
Arteriovenous Malformation (AVM)
Trigeminal Neuralgia
Others

By End User:

Hospitals
Specialty Clinics
Radiotherapy Centers
Others

By Region:

North America
- U.S.
- Canada
Europe
- Germany
- U.K.
- France
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- Indonesia
- Malaysia
- South Korea
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa

For more insights into the Gamma Knife System Market and its future trends, visit link below: https://www.prophecymarketinsights.com/market_insight/Global-Gamma-Knife-System-Market-2751

Competitive Landscape of Gamma Knife System Market:

The companies operating in the market include, Elekta, Varian, ACIBADEM HEALTHCARE SERVICES, GE HealthCare, Brainlab, Accuray Incorporated, Akesis, Inc., ECU Health, Fortis Healthcare, Masep Medical Science & Technology Development Co., Ltd., and Sotera Health